Kids Disease Child Disease Encyclopedia
Illustration representing Kawasaki Disease
Emergency Acquired Inflammatory Vascular Pathologies

Kawasaki Disease

Acute Systemic Medium-Vessel Vasculitis

Primary risk age: Children under 5 years (Highest prevalence in children of Asian descent)

Urgency
Emergency
Typical age
Children under 5 years (Highest prevalence in children of Asian descent)
Body system
Cardiovascular System

Typical course: Acute hospital phase lasts 3 to 7 days; full convalescent tissue repair takes 6 to 8 weeks.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Acute Systemic Medium-Vessel Vasculitis

Pathophysiology (Development Path)

An inflammatory cascade targets the endothelial and smooth muscle cells of medium-sized arteries, particularly the coronary arteries. Neutrophils, followed by T-lymphocytes and macrophages, infiltrate the vascular walls, breaking down elastin and collagen. This weakens the structural integrity of the vessels, leading to aneurysms.

Primary Causes & Etiology

Unknown etiology; believed to be triggered by an unclassified infectious agent that prompts an exaggerated auto-inflammatory immune response in genetically predisposed individuals.

2. Symptom Continuum

  1. Early Onset Signs

    High spikes of unremitting fever (often >39°C) lasting at least 5 days, bilateral non-purulent conjunctival injection, and erythema of the lips and oral mucosa ("strawberry tongue").

  2. Progressive Phase

    Polymorphous macular rash on the trunk, firm induration of the hands and feet with vivid palmar and plantar erythema, and unilateral non-suppurative cervical lymphadenopathy (>1.5 cm).

  3. Severe Indicators

    Desquamation (peeling) of the skin starting under the nails, acute myocarditis marked by tachycardia out of proportion to the fever, gallop rhythms, and signs of congestive heart failure.

3. Clinical Verification

Clinical diagnosis based on the criteria of a 5-day fever plus at least 4 out of 5 classic mucocutaneous signs. Echocardiography is performed immediately to evaluate the coronary arteries.

4. Care & Elements Plan

Primary Care Treatment Plan

Aims to reduce vascular wall inflammation and prevent coronary artery thrombosis. Administer high-dose immunoglobulins and high-dose salicylate therapy early in the illness.

Home Support Elements

This condition requires immediate inpatient hospitalization. Home care is limited to post-discharge tracking for a return of fever or bleeding risks related to therapeutic blood thinners.

Generic Active Ingredients (No Brands)

  • Intravenous Immunoglobulin (IVIG - to suppress systemic vascular immune damage)
  • Acetylsalicylic acid (Aspirin - given at high anti-inflammatory doses initially, then switched to low anti-platelet doses).

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

Any child running an unexplained high fever for more than 4-5 days accompanied by bloodshot eyes, red cracked lips, or a widespread rash requires immediate emergency pediatric evaluation.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

No preventative methods or lifestyle modifications exist, as the primary trigger remains unclassified.

Immunization Context

No immunization exists. Note that high-dose IVIG therapy requires delaying live viral vaccines (such as MMR and Varicella) for 11 months.

7. Timelines & Outlook

Active Timeline

Acute hospital phase lasts 3 to 7 days; full convalescent tissue repair takes 6 to 8 weeks.

Expected Prognosis

Excellent if treated within the first 10 days of onset, reducing the risk of coronary aneurysms from 25% to under 5%.

Potential Untreated Complications

Coronary artery aneurysms, myocardial infarction, pericarditis, and sudden cardiac death.